Biodexa Pharmaceuticals (BDRX) Operating Expenses (2013 - 2025)

Biodexa Pharmaceuticals (BDRX) posted Operating Expenses of -$5.4 million for Q2 2025, little changed sequentially from -$5.4 million in Q4 2024.

Biodexa Pharmaceuticals (BDRX) Operating Expenses (2013 - 2025) Analysis & Trends

Biodexa Pharmaceuticals has reported Operating Expenses for 12 years, with the latest figure at -$5.4 million in Q2 2025.

Quarterly Operating Expenses changed N/A year-over-year to -$5.4 million in Q2 2025, while the trailing twelve-month figure through Dec 2025 was -$10.8 million (up 2.61% YoY) and the FY2025 annual result came in at -$11.6 million, up 2.09% from the prior year.
Operating Expenses held at -$5.4 million in Q2 2025 per BDRX's latest filing, from -$5.4 million in the prior quarter.
Over five years, Operating Expenses peaked at -$4.9 million in Q4 2021 and troughed at -$5.7 million in Q2 2023.
A 5-year average of -$5.3 million and a median of -$5.3 million in 2022 frame the typical range for Operating Expenses.
The sharpest annual moves came in 2021 and 2022: Operating Expenses soared 66.04% in 2021, then decreased 4.04% in 2022.
Over 5 years, Operating Expenses stood at -$4.9 million in 2021, then slipped by 1.16% to -$5.0 million in 2022, then retreated by 13.7% to -$5.7 million in 2023, then climbed by 4.64% to -$5.4 million in 2024, then increased by 0.49% to -$5.4 million in 2025.
According to Business Quant data, Operating Expenses over the past three periods registered -$5.4 million, -$5.4 million, and -$5.7 million for Q2 2025, Q4 2024, and Q2 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Opex (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	2.09 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	3.00 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	2.89 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	960.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	1.21 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	1.06 Bn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	427.03 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	541.02 Mn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-784.57 Mn
10	Biodexa Pharmaceuticals	63,168.17	-11.29 Mn	-	-

Download Data